Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: Activation of plasminogen activator inhibitor 1 expression

Endocrinology

Volumn 139, Issue 9, 1998, Pages 3696-3703

  Lee, Hsinyu ^a   Struman, Ingrid ^b   Clapp, Carman ^c   Martial, Joseph ^b   Weiner, Richard I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; PLASMINOGEN ACTIVATOR; PROLACTIN; PROTEIN; PROTEINASE; UROKINASE;

ANGIOGENESIS; ARTICLE; CELL CULTURE; CELL MIGRATION; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HORMONAL REGULATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; NORTHERN BLOTTING; PRIORITY JOURNAL;

EID: 0031730107     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.139.9.6194     Document Type: Article

References (38)

1. Folkman J, Klagsburn M 1987 Angiogenic factors. Science 235:442-447
2. Hanahan D, Folkman J 1996 Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364
3. Esch F, Baird A, Ling N, Ueno N, Hill F, Denoroy F, Klepper R, Gospodarowicz D, Bohlen P, Guillemin R 1985 Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF. Proc Natl Acad Sci USA 82:6507-6511
4. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N 1989 Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309
5. Felt JW, Strydom DJ, Lobb RR, Alderman EM, Bethune JL, Riordan JF, Vallee BL 1985 Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24:5480-5486
6. Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP 1990 A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628
7. Ferrara N, Clapp C, Weiner R 1991 The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129:896-900
8. Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE 1990 Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 82:848-853
9. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J 1994 Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [see comments]. Cell 79:315-328
10. Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI 1993 The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133:1292-1299
11. Saksela O, Rifkin DB 1988 Cell-associated plasminogen activation: regulation and physiological functions. Annu Rev Cell Biol 4:93-126
12. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L 1985 Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266
13. Vassalli JD, Sappino AP, Belin D 1991 The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072
14. Werb Z, Mainardi CL, Vater CA, Harris Jr E 1977 Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med 296:1017-1023
15. Pepper MS, Vassalli JD, Montesano R, Orci L 1987 Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells. J Cell Biol 105:2535-2541
16. Odekon LE, Sato Y, Rifkin DB 1992 Urokinase-type plasminogen activator mediates basic fibroblast growth factor-induced bovine endothelial cell migration independent of its proteolytic activity. J Cell Physiol 150:258-263
17. Fibbi G, Ziehe M, Morbidelli L, Magnelli L, Del Rosso M 1988 Interaction of urokinase with specific receptors stimulates mobilization of bovine adrenal capillary endothelial cells [published erratum appears in Exp Cell Res 1990 Jan;186(1):196]. Exp Cell Res 179:385-395
18. Pepper MS, Montesano R 1990 Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319-327
19. Laiho M, Saksela O, Andreasen PA, Keski-Oja J 1986 Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-beta. J Cell Biol 103:2403-2410
20. Mimuro J, Schleef RR, Loskutoff DJ 1987 Extracellular matrix of cultured bovine aortic endothelial cells contains functionally active type 1 plasminogen activator inhibitor. Blood 70:721-728
21. Saksela O, Moscatelli D, Rifkin DB 1987 The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 105:957-963
22. Hekman CM, Loskutoff DJ 1987 Fibrinolytic pathways and the endothelium. Semin Thromb Hemost 13:514-527
23. Pepper MS, Belin D, Montesano R, Orci L, Vassalli JD 1990 Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro. J Cell Biol 111:743-755
24. D'Angelo G, Struman I, Martial J, Weiner RI 1995 Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the anti-angiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 92:6374-6378
25. Gospodarowicz D, Cheng J 1986 Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128:475-484
26. Blei F, Wilson EL, Mignatti P, Rifkin DB 1993 Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J Cell Physiol 155:568-578
27. Werner S, Duan DS, de Vries C, Peters KG, Johnson DE, William LT 1992 Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities. Mol Cell Biol 12:82-88
28. Moscatelli D 1986 Urokinase-type and tissue-type plasminogen activators have different distributions in cultured bovine capillary endothelial cells. J Cell Biochem 30:19-29
29. Niiya K, Shinbo M, Ozawa T, Hayakawa Y, Sakuragawa N 1995 Modulation of urokinase-type plasminogen activatorgene expression by inflammatory cytokines in human pre-B lymphoma cell line RC-K8. Thromb Haemost 74:1511-1515
30. Li J, Croze F, Yan W, Hache RJ, Tsang BK 1997 Up-regulation of urokinase plasminogen activator messenger ribonuleic acid and protein in hen granulosa cells by transforming growth factor alpha in vitro during follicular development. Biol Reprod 56:1317-1322
31. Manchanda N, Schwartz BS 1995 Interaction of single-chain urokinase and plasminogen activator inhibitor type 1. J Biol Chem 270:20032-20035
32. Sawdey M, Podor TJ, Loskutoff DJ 1989 Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. J Biol Chem 264:10396-10401
33. Bagavandoss P, Kaytes P, Vogeli G, Wells PA, Wilks JW 1993 Recombinant truncated thrombospondin-1 monomer modulates endothelial cell plasminogen activator inhibitor 1 accumulation and proliferation in vitro. Biochem Biophys Res Commun 192:325-332
34. Pepper MS, Ferrara N, Orci L, Montesano R 1995 Leukemia inhibitory factor (LIF) inhibits angiogenesis in vitro. J Cell Sci 108:73-83
35. Niedbala MJ, Stein-Picarella M 1992 Tumor necrosis factor regulation of endothelial cell extracellular proteolysis: the role of urokinase plasminogen activator. Biol Chem Hoppe Seyler 373:555-566
36. Slivka SR, Loskutoff DJ 1991 Regulation of type 1 plasminogen activator inhibitor synthesis by protein kinase C and cAMP in bovine aortic endothelial cells. Biochim Biophys Acta 1094:317-322
37. Petzelbauer E, Springhorn JP, Tucker AM, Madri JA 1996 Role of plasminogen activator inhibitor in the reciprocal regulation of bovine aortic endothelial and smooth muscle cell migration by TGF-beta 1. Am J Pathol 149:923-931
38. Madri JA, Bell L, Merwin JR 1992 Modulation of vascular cell behavior by transforming growth factors beta. Mol Reprod Dev 32:121-126